$1.58
1.28% yesterday
Nasdaq, Dec 23, 10:00 pm CET
ISIN
CA68620P1018
Symbol
OGI
Sector
Industry

OrganiGram Holdings Inc Stock price

$1.58
+0.00 0.00% 1M
+0.01 0.64% 6M
+0.27 20.61% YTD
+0.32 25.40% 1Y
-6.42 80.25% 3Y
-8.30 84.01% 5Y
-0.64 28.96% 10Y
Nasdaq, Closing price Mon, Dec 23 2024
+0.02 1.28%
ISIN
CA68620P1018
Symbol
OGI
Sector
Industry

Key metrics

Market capitalization $171.56m
Enterprise Value $76.10m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 39.03
EV/Sales (TTM) EV/Sales 0.65
P/S ratio (TTM) P/S ratio 1.46
P/B ratio (TTM) P/B ratio 0.76
Revenue growth (TTM) Revenue growth -2.03%
Revenue (TTM) Revenue $117.45m
EBIT (operating result TTM) EBIT $-63.84m
Free Cash Flow (TTM) Free Cash Flow $1.95m
Cash position $98.76m
EPS (TTM) EPS $-0.38
Short interest 5.92%
Show more

Is OrganiGram Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

OrganiGram Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a OrganiGram Holdings Inc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a OrganiGram Holdings Inc forecast:

Buy
80%
Hold
20%

Financial data from OrganiGram Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
117 117
2% 2%
100%
- Direct Costs 123 123
16% 16%
105%
-5.49 -5.49
79% 79%
-5%
- Selling and Administrative Expenses 41 41
18% 18%
35%
- Research and Development Expense 8.23 8.23
16% 16%
7%
-55 -55
22% 22%
-47%
- Depreciation and Amortization 8.88 8.88
54% 54%
8%
EBIT (Operating Income) EBIT -64 -64
29% 29%
-54%
Net Profit -34 -34
82% 82%
-29%

In millions USD.

Don't miss a Thing! We will send you all news about OrganiGram Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OrganiGram Holdings Inc Stock News

Positive
Seeking Alpha
one day ago
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cannabis LP Motif Labs which will set Organigram in the top spot in Canada by market share. Organigram has increased its international footprint with an investment in Sanity Group in Germany and in Ope...
Neutral
Seeking Alpha
5 days ago
Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Yewon Kang - Canaccord Genuity Operator Good mo...
Positive
Market Watch
6 days ago
Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.
More OrganiGram Holdings Inc News

Company Profile

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Head office Canada
CEO Beena Goldenberg
Employees 898
Founded 2010
Website www.organigram.ca

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today